rs727503930

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BP6BS2

The NM_001110556.2(FLNA):​c.7172G>A​(p.Arg2391His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,210,274 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 36 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2391C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 25)
Exomes 𝑓: 0.000084 ( 0 hom. 36 hem. )

Consequence

FLNA
NM_001110556.2 missense

Scores

8
8
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 7.82

Publications

4 publications found
Variant links:
Genes affected
FLNA (HGNC:3754): (filamin A) The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
FLNA Gene-Disease associations (from GenCC):
  • periventricular nodular heterotopia
    Inheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • frontometaphyseal dysplasia 1
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • heterotopia, periventricular, X-linked dominant
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
  • intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Melnick-Needles syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • otopalatodigital syndrome type 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • terminal osseous dysplasia-pigmentary defects syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • cardiac valvular dysplasia, X-linked
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • frontometaphyseal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital short bowel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • otopalatodigital syndrome type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Ehlers-Danlos syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.833
BP6
Variant X-154350192-C-T is Benign according to our data. Variant chrX-154350192-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 167077.
BS2
High Hemizygotes in GnomAdExome4 at 36 XL,AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNANM_001110556.2 linkc.7172G>A p.Arg2391His missense_variant Exon 45 of 48 ENST00000369850.10 NP_001104026.1
FLNANM_001456.4 linkc.7148G>A p.Arg2383His missense_variant Exon 44 of 47 NP_001447.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNAENST00000369850.10 linkc.7172G>A p.Arg2391His missense_variant Exon 45 of 48 1 NM_001110556.2 ENSP00000358866.3

Frequencies

GnomAD3 genomes
AF:
0.00000887
AC:
1
AN:
112683
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000716
AC:
13
AN:
181611
AF XY:
0.0000445
show subpopulations
Gnomad AFR exome
AF:
0.0000806
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000147
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000838
AC:
92
AN:
1097591
Hom.:
0
Cov.:
31
AF XY:
0.0000992
AC XY:
36
AN XY:
363053
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26397
American (AMR)
AF:
0.0000284
AC:
1
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54138
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40310
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4133
European-Non Finnish (NFE)
AF:
0.000106
AC:
89
AN:
841764
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000887
AC:
1
AN:
112683
Hom.:
0
Cov.:
25
AF XY:
0.00
AC XY:
0
AN XY:
34853
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30992
American (AMR)
AF:
0.00
AC:
0
AN:
10743
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3582
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2789
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6218
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53262
Other (OTH)
AF:
0.00
AC:
0
AN:
1520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000743
AC:
9
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:1
Jan 18, 2023
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 19, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 08, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The FLNA c.7148G>A; p.Arg2383His variant (rs727503930) is reported in the literature in an individual affected with otopalatodigital syndrome; however, the variant was detected in the patient’s unaffected mother who was shown to have random X chromosome inactivation (Moutton 2016). This variant is also reported in ClinVar (Variation ID: 167077), and is found in the non-Finnish European population with an allele frequency of 0.015% (12/81,373 alleles, including 3 hemizygotes) in the Genome Aggregation Database. The arginine at codon 2383 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.827). However, given the lack of clinical and functional data, the significance of this variant is uncertain at this time. References: Moutton S et al. Otopalatodigital spectrum disorders: refinement of the phenotypic and mutational spectrum. J Hum Genet. 2016 Aug;61(8):693-9. PMID: 27193221. -

Feb 03, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27193221) -

Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Dec 12, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R2383H variant (also known as c.7148G>A), located in coding exon 43 of the FLNA gene, results from a G to A substitution at nucleotide position 7148. The arginine at codon 2383 is replaced by histidine, an amino acid with highly similar properties. This alteration, reported as p.R2391H, has been detected in a female with clinical symptoms compatible with otopalatodigital syndrome. However, the patient also exhibited atypical findings, did not exhibit skewed X-inactivation, and inherited the variant from her unaffected mother also with random X-inactivation (Moutton S et al. J Hum Genet, 2016 Aug;61:693-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on data from gnomAD, the A allele has an overall frequency of 0.007% (13/181611) total alleles studied, with 3 hemizygote(s) observed. The highest observed frequency was 0.01% (12/81373) of non-Finnish European alleles. Based on the available evidence, the clinical significance of this variant remains unclear. -

Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.57
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.49
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
D;.;.;.;.
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Pathogenic
0.99
D;D;.;D;D
M_CAP
Pathogenic
0.43
D
MetaRNN
Pathogenic
0.83
D;D;D;D;D
MetaSVM
Uncertain
0.60
D
MutationAssessor
Uncertain
2.4
M;.;.;.;.
PhyloP100
7.8
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-4.2
D;.;D;D;.
REVEL
Pathogenic
0.83
Sift
Uncertain
0.019
D;.;D;D;.
Sift4G
Uncertain
0.0020
D;D;D;D;D
Polyphen
1.0
D;.;P;P;.
Vest4
0.71
MutPred
0.57
Gain of sheet (P = 0.0344);.;.;.;.;
MVP
0.99
MPC
1.6
ClinPred
0.51
D
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.80
gMVP
0.55
Mutation Taster
=66/34
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503930; hg19: chrX-153578560; COSMIC: COSV61047078; COSMIC: COSV61047078; API